Literature DB >> 1658777

In situ processing of a retroviral nucleocapsid protein by the viral proteinase.

M M Roberts1, T D Copeland, S Oroszlan.   

Abstract

The proteolytic processing pathway of the nucleocapsid protein (NC) by the viral proteinase within intact capsids of equine infectious anemia virus (EIAV) is presented. The cleavage sites are located at the carboxyl side of the first cysteine residue within the zinc-finger domains. EIAV is used as a model to predict similar NC cleavages in other retroviruses, including human immunodeficiency virus (HIV). The observed cleavages suggest a previously unrecognized function of the retroviral proteinase that may be crucial for replication during the early stages of the virus life-cycle (i.e. reverse transcription/integration).

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1658777     DOI: 10.1093/protein/4.6.695

Source DB:  PubMed          Journal:  Protein Eng        ISSN: 0269-2139


  17 in total

1.  Progression of early steps of human immunodeficiency virus type 1 replication in the presence of an inhibitor of viral protease.

Authors:  H Jacobsen; L Ahlborn-Laake; R Gugel; J Mous
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

2.  Genetic analysis of the zinc finger in the Moloney murine leukemia virus nucleocapsid domain: replacement of zinc-coordinating residues with other zinc-coordinating residues yields noninfectious particles containing genomic RNA.

Authors:  R J Gorelick; D J Chabot; D E Ott; T D Gagliardi; A Rein; L E Henderson; L O Arthur
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

3.  Conditional human immunodeficiency virus type 1 protease mutants show no role for the viral protease early in virus replication.

Authors:  A H Kaplan; M Manchester; T Smith; Y L Yang; R Swanstrom
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

4.  Molecular analysis of the feline immunodeficiency virus protease: generation of a novel form of the protease by autoproteolysis and construction of cleavage-resistant proteases.

Authors:  G S Laco; M C Fitzgerald; G M Morris; A J Olson; S B Kent; J H Elder
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

5.  Biochemical and structural analysis of isolated mature cores of human immunodeficiency virus type 1.

Authors:  R Welker; H Hohenberg; U Tessmer; C Huckhagel; H G Kräusslich
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

6.  Alteration of zinc-binding residues of simian immunodeficiency virus p8(NC) results in subtle differences in gag processing and virion maturation associated with degradative loss of mutant NC.

Authors:  J L Yovandich; E N Chertova; B P Kane; T D Gagliardi; J W Bess; R C Sowder; L E Henderson; R J Gorelick
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

7.  Cleavage of p15 protein in vitro by human immunodeficiency virus type 1 protease is RNA dependent.

Authors:  N Sheng; S Erickson-Viitanen
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

8.  Structure of equine infectious anemia virus proteinase complexed with an inhibitor.

Authors:  A Gustchina; J Kervinen; D J Powell; A Zdanov; J Kay; A Wlodawer
Journal:  Protein Sci       Date:  1996-08       Impact factor: 6.725

9.  Identification of proteolytic processing sites within the Gag and Pol polyproteins of feline immunodeficiency virus.

Authors:  J H Elder; M Schnölzer; C S Hasselkus-Light; M Henson; D A Lerner; T R Phillips; P C Wagaman; S B Kent
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

10.  Antiviral activity of human immunodeficiency virus type 1 protease inhibitors in a single cycle of infection: evidence for a role of protease in the early phase.

Authors:  K Nagy; M Young; C Baboonian; J Merson; P Whittle; S Oroszlan
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.